GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,641.00p
   
  • Change Today:
      13.50p
  • 52 Week High: 1,671.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,064.70m
  • Volume: 635,976
  • Market Cap: £66,702m
  • RiskGrade: 129

Trump to impose tariffs of 100% on branded drug imports

By Abigail Townsend

Date: Friday 26 Sep 2025

LONDON (ShareCast) - (Sharecast News) - Donald Trump is to impose tariffs of 100% on imports of pharmaceutical goods, it emerged on Friday, the latest salvo in the US president's global trade war.
Posting on Truth Social, Trump said the levies would be imposed on any branded or patented pharmaceutical product from 1 October.

However, drugs companies could be exempt if they are already building manufacturing facilities in the US.

"There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started," he wrote "Thank you for your attention to this matter!"

A number of pharmaceutical companies worldwide - including AstraZeneca and GSK - have recently announced major US investment plans, in light of long-threatened tariffs on the sector. However, construction may not have started, due to the complex nature of manufacturing across the sector.

The Social Media post was one of several updates on tariffs made by the president early on Friday morning.

He announced a separate 50% tariff on imports of kitchen cabinets and bathroom vanities, also starting from 1 October, and a 30% tax on upholstered furniture.

"The reason for this is the large scale 'FLOODING' of these products into the United States by other outside Countries," he wrote.

In addition, Trump said "all heavy (big!) trucks" made outside of America will be subject to a 25% import charge, to protect US manufacturers from "the onslaught of outside interruptions".

Kathleen Brooks, research director at XTB, said: "This is a reminder that Trump's tariffs are never finished. When we think we can move on from the threat of tariffs, they raise their head once more. The next set of tariffs could be directed at semiconductors and critical rare earth minerals in a number of weeks."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,641.00p
Change Today 13.50p
% Change 0.83 %
52 Week High 1,671.50p
52 Week Low 1,264.00p
Volume 635,976
Shares Issued 4,064.70m
Market Cap £66,702m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 14
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 14-Oct-2025

Time Volume / Share Price
11:00 0 @ 1,641.50p
11:00 0 @ 1,641.50p
11:00 410 @ 1,641.00p
11:00 10 @ 1,641.00p
11:00 138 @ 1,641.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page